<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Mirum Pharmaceuticals, Inc.

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Mirum Pharmaceuticals, Inc.

    Mirum Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. The company’s lead product candidate, maralixibat, is an investigational oral drug in development for progressive familial intrahepatic cholestasis (PFIC) and Alagille syndrome (ALGS). Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $345,000,000
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Chris Peetz
    • FOUNDED
      2018
    • EMPLOYEES
      20
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    T2 Biosystems, Inc.

    T2 Biosystems, Inc.

    T2 Biosystems, a leader in the development and commercialization of innovative med...

    T2 Biosystems, a leader in the development and ...

    Filing Type:    PU
    Neos Therapeutics, Inc.

    Neos Therapeutics, Inc.

    Neos Therapeutics develops, manufactures, and commercializes innovative extended-r...

    Neos Therapeutics develops, manufactures, and c...

    Filing Type:    PU
    Premier, Inc.

    Premier, Inc.

    Premier operates one of the nation’s largest performance improvement alliances o...

    Premier operates one of the nation’s largest ...

    Filing Type:    PU
    Soligenix, Inc.

    Soligenix, Inc.

    Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing an...

    Soligenix, Inc. is a late-stage biopharmaceutic...

    Filing Type:    PU
    Verona Pharma plc

    Verona Pharma plc

    Verona Pharma plc is a clinical stage biopharmaceutical company focused on the dev...

    Verona Pharma plc is a clinical stage biopharma...

    Filing Type:    PU
    Novus Therapeutics, Inc.

    Novus Therapeutics, Inc.

    Novus Therapeutics, Inc. is a specialty pharmaceutical company focused on developi...

    Novus Therapeutics, Inc. is a specialty pharmac...

    Filing Type:    PU
    Gemphire Therapeutics Inc.

    Gemphire Therapeutics Inc.

    Gemphire Therapeutics Inc. (NASDAQ:GEMP) is a clinical‑stage biopharmaceutical c...

    Gemphire Therapeutics Inc. (NASDAQ:GEMP) is a c...

    Filing Type:    PU
    Cyclerion Therapeutics, Inc.

    Cyclerion Therapeutics, Inc.

    Cyclerion Therapeutics is a clinical-stage biopharmaceutical company harnessing th...

    Cyclerion Therapeutics is a clinical-stage biop...

    Filing Type:    PU
    Hepion Pharmaceuticals, Inc.

    Hepion Pharmaceuticals, Inc.

    Hepion Pharmaceuticals (Nasdaq: HEPA) is a clinical stage biopharmaceutical compan...

    Hepion Pharmaceuticals (Nasdaq: HEPA) is a clin...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.